A. Zetterlund et al., EFFECTS OF BETA(2)-AGONISTS AND BUDESONIDE ON INTERLEUKIN-1-BETA AND LEUKOTRIENE B-4 SECRETION - STUDIES OF HUMAN MONOCYTES AND ALVEOLAR MACROPHAGES, The Journal of asthma, 35(7), 1998, pp. 565-573
The aims of the present study were to determine whether beta(2)-agonis
ts (short- and long-acting) and a glucocorticoid (budesonide) influenc
e the secretion of a pro-inflammatory cytokine (interleukin-1, [IL-1])
and a granulocyte attractant (leukotriene B-4 [LTB4]) and to compare
these effects on blood monocyte and alveolar macrophages. Alveolar mac
rophages (obtained by bronchoalveolar lavage) and blood monocytes from
26 healthy nonsmokers were stimulated with lipopolysaccharide or huma
n serum opsonized zymosan. The influence of four beta(2)-agonists (sal
butamol, terbutaline, formoterol, and salmeterol) and a corticosteroid
(budesonide) on the release of interleukin-1 beta (IL-1 beta) and LTB
4 was studied in a dose-response manner (10(-8)-10(-5) mol/L for beta(
2)-agonists and 10(-10)-10(-6) mol/L for budesonide). The stimulated I
L-1 beta secretion was significantly greater in blood monocytes than i
n alveolar macrophages (p < 0.05), but alveolar macrophages were much
more capable of secreting LTB4 than were blood monocytes (p < 0.001).
Budesonide significantly inhibited the release of IL-1 beta from blood
monocytes (p < 0.001), but no such effect was observed in alveolar ma
crophages. Budesonide did not influence the release of LTB4 in either
cell type. The beta(2)-agonists neither influenced the LTB4 nor the IL
-beta secretion in either cell type with the exception of formoterol,
which stimulated IL-1 beta secretion at the highest concentration (10(
-5) mol/L, p<0.05). In conclusion, beta(2)-agonists exhibited only min
or effects on IL-1 beta secretion from blood monocytes and no effect o
n LTB4-secretion from either cell type, and budesonide effectively inh
ibited the IL-1 beta release in blood monocytes, but not in alveolar m
acrophages. Thus, induced secretion of LTB4 and IL-1 beta, and the sen
sitivity to corticosteroids with regard to IL-1 beta secretion, change
during the transformation from blood monocytes to alveolar macrophage
s.